Rephonic
Artwork for VJHemOnc Podcast

VJHemOnc Podcast

VJHemOnc
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Multiple Myeloma
BTK Inhibitors
Clinical Trials
Venetoclax
CAR T-Cell Therapy
Mantle Cell Lymphoma
Myeloproliferative Neoplasms
Myelodysplastic Syndromes
Sickle Cell Disease
Immunotherapy
Measurable Residual Disease
Car-T Therapy
Bispecific Antibodies
Menin Inhibitors
Gene Therapy
Artificial Intelligence
Amyloidosis
Non-Hodgkin Lymphoma

The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including ... more

PublishesWeeklyEpisodes296Founded9 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for VJHemOnc Podcast

Latest Episodes

This episode of the VJHemOnc podcast features an exclusive expert-led roundtable discussion summarizing two sessions from the 8th International Workshop on Acute Leukemias (iwAL 2026) that focused on novel targets, combinations, and treatments in acu... more

YouTube

In this episode of the VJHemOnc podcast, experts discuss key advances in multiple myeloma presented at the 23rd Annual Meeting and Exposition of the International Myeloma Society (IMS 2026) in Glasgow, UK. Pieter Sonneveld, MD, PhD, Erasmus MC, Rotte... more

YouTube

This VJHemOnc podcast explores how BTK inhibitor therapy can be personalized for patients with chronic lymphocytic leukemia (CLL), considering disease biology, patient characteristics and treatment goals.

Kerry Rogers, MD, The Ohio State University,... more

YouTube

This episode of the VJHemOnc podcast, featuring Manali Kamdar, MD, University of Colorado Cancer Center, Denver, CO, focuses on the practical use of BTK inhibitors (BTKis) in non-Hodgkin lymphoma (NHL). Dr Kamdar begins by discussing which factors gu... more

YouTube

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Blood Cancer Talks
Blood Cancer TalksRajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
EHA Unplugged
EHA UnpluggedEuropean Hematology Association
Blood Podcast
Blood PodcastAmerican Society of Hematology
WolverHeme Happy Hour
WolverHeme Happy HourBernard Marini, Anthony Perissinotti, et al.

Recent Guests

Kerry Rogers
CLL/BTK inhibitor treatment strategy expert
Episode: Personalizing BTK Inhibitor Therapy in CLL: from treatment selection to long-term management
Florian Simon
Cardiovascular risk and comorbidity specialist in BTK inhibitor therapy
Episode: Personalizing BTK Inhibitor Therapy in CLL: from treatment selection to long-term management
Gianluca Gaidano
Hematology expert discussing BTK inhibitors and sequencing after resistance
Episode: Personalizing BTK Inhibitor Therapy in CLL: from treatment selection to long-term management
Dima El-Sharkawi
Clinical expert discussing quality of life and shared decision-making in CLL
Episode: Personalizing BTK Inhibitor Therapy in CLL: from treatment selection to long-term management
Manali Kamdar
Focused on practical use of BTK inhibitors in lymphoma
Episode: Using BTK inhibitors in lymphoma: practical considerations for community physicians
Radek Kaczmarek
Researcher at Indiana University School of Medicine
Indiana University School of Medicine
Episode: AAV gene therapy in hemophilia: progress, challenges and what comes next
Martin Schrappe
Researcher discussing pediatric ALL trial with Blinitumumab replacing high-dose chemotherapy
Episode: The evolving treatment landscape in ALL: the growing role of immunotherapy and reduced reliance on chemotherapy
Bijal Shah
Physician-scientist discussing CAR T cells and B-ALL/B-ALL frontline strategies
Moffitt Cancer Center
Episode: The evolving treatment landscape in ALL: the growing role of immunotherapy and reduced reliance on chemotherapy
Ibrahim Aldos
Speaker discussing CAR T and bispecifics at IW CAR-T 2026
City of Hope / City of Hobb
Episode: The evolving treatment landscape in ALL: the growing role of immunotherapy and reduced reliance on chemotherapy

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

The evolving treatment landscape in ALL: the growing role of immunotherapy and reduced reliance on chemotherapy
Q: What is driving the shift toward immunotherapy in ALL, and how might chemotherapy be reduced in frontline regimens?
Immunotherapies such as bispecific antibodies, ADCs, and CAR T cells are delivering high efficacy with different toxicity profiles, enabling a move away from intensive chemotherapy in select patient groups, particularly in pediatric high-risk ALL, with a goal of maintaining outcomes while decreasing treatment burden.
The diagnosis and management of hematologic malignancies during pregnancy
Q: What changes in diagnostic workup are used for pregnant patients with suspected hematologic malignancies?
Imaging shifts from PET/CT to MRI to avoid ionizing radiation; bone marrow puncture remains feasible when necessary, and disease-specific staging relies on safe modalities.
The diagnosis and management of hematologic malignancies during pregnancy
Q: Why is the management of hematologic malignancies during pregnancy becoming more important today?
Because diagnostic tools like non-invasive prenatal testing can reveal maternal cancers, and certain malignancies like Hodgkin lymphoma and ALL occur in younger women, making pregnancy-associated cases more common and clinically relevant.
Managing and preventing differentiation syndrome in APL
Q: Where does steroid prophylaxis fit in today's APL treatment protocols?
Steroid prophylaxis remains controversial, with some evidence supporting its use in high-risk patients but lacking consensus on the best practices.
Managing and preventing differentiation syndrome in APL
Q: Could you discuss how the evidence supporting steroid prophylaxis has evolved over time?
Evidence supporting steroid prophylaxis has evolved with various studies showing varying results on its efficacy in reducing differentiation syndrome.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About VJHemOnc Podcast

What is VJHemOnc Podcast about and what kind of topics does it cover?

The program consistently features leading clinicians, researchers, and trialists who discuss hematology and hematologic oncology across a broad spectrum of diseases, including leukemias, lymphomas, MDS, MPNs, sickle cell disease, and related therapies. Episodes frequently center on cutting-edge treatments such as CAR T cells, BTK inhibitors, gene therapies, and precision medicine approaches, often contrasting new therapies with traditional regimens and exploring frontline versus relapse strategies. A notable strength is the roundtable and expert-panel format that surfaces practical insights on trial design, real-world implementation, toxicity management, and patient selection, making it valuable for healthcare professionals seeking to stay ... more

Where can I find podcast stats for VJHemOnc Podcast?

Rephonic provides a wide range of podcast stats for VJHemOnc Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to VJHemOnc Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does VJHemOnc Podcast get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for VJHemOnc Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for VJHemOnc Podcast?

Rephonic provides comprehensive predictive audience data for VJHemOnc Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does VJHemOnc Podcast have?

To see how many followers or subscribers VJHemOnc Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to VJHemOnc Podcast?

These podcasts share a similar audience with VJHemOnc Podcast:

1. Blood Cancer Talks
2. EHA Unplugged
3. Hematologic Oncology Update
4. Blood Podcast
5. WolverHeme Happy Hour

How many episodes of VJHemOnc Podcast are there?

VJHemOnc Podcast launched 9 years ago and published 296 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact VJHemOnc Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for VJHemOnc Podcast?

Rephonic pulls ratings and reviews for VJHemOnc Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for VJHemOnc Podcast?

Rephonic provides full transcripts for episodes of VJHemOnc Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on VJHemOnc Podcast?

Recent guests on VJHemOnc Podcast include:

1. Kerry Rogers
2. Florian Simon
3. Gianluca Gaidano
4. Dima El-Sharkawi
5. Manali Kamdar
6. Radek Kaczmarek
7. Martin Schrappe
8. Bijal Shah

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days